Key Insights

Highlights

Success Rate

98% trial completion (above average)

Published Results

14 trials with published results (18%)

Research Maturity

57 completed trials (73% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.3%

1 terminated out of 78 trials

Success Rate

98.3%

+11.8% vs benchmark

Late-Stage Pipeline

18%

14 trials in Phase 3/4

Results Transparency

25%

14 of 57 completed with results

Key Signals

14 with results98% success

Data Visualizations

Phase Distribution

70Total
Not Applicable (36)
P 1 (7)
P 2 (13)
P 3 (11)
P 4 (3)

Trial Status

Completed57
Recruiting7
Unknown7
Not Yet Recruiting3
Withdrawn2
Enrolling By Invitation1

Trial Success Rate

98.3%

Benchmark: 86.5%

Based on 57 completed trials

Clinical Trials (78)

Showing 20 of 20 trials
NCT06807489Completed

Disordered Eating Risk in Pediatric Obesity Treatment Using a Digi-Physical Tool

NCT07435974Not ApplicableRecruitingPrimary

COR Protocol for the Treatment of Binge Eating in Chilean Adults (COR)

NCT07301541Not ApplicableNot Yet RecruitingPrimary

Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents

NCT06604299Not ApplicableCompletedPrimary

Digital Mindfulness Meditation-enhanced Cognitive Behavioral Therapy (CBT-MM) for Binge Eating Disorder

NCT07327203Not ApplicableRecruitingPrimary

Video-based Guided Self Help Dialectical Behavior Therapy for Binge Eating Disorder

NCT07295470Not ApplicableNot Yet Recruiting

Sleep and Activity For Eating Disorders

NCT07212673Not ApplicableRecruitingPrimary

Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder

NCT02940613Not ApplicableTerminated

Using Visual Feedback to Influence Rapid Response in the Treatment of Eating Disorders

NCT06847399Phase 2Recruiting

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

NCT07042672Recruiting

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

NCT05897398Completed

SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®

NCT03234881Not ApplicableCompletedPrimary

Weight Loss Treatment for Veterans With Binge Eating

NCT06823557Phase 1Not Yet RecruitingPrimary

Investigation of the Mechanisms of the Gut-brain Axis in Binge Eating and Obesity.

NCT06779838Not ApplicableEnrolling By Invitation

Effectiveness of Group EFT for Transdiagnostic Eating Disorders/Difficulties Within Student Counselling Services.

NCT04876183Not ApplicableCompletedPrimary

Evaluation of a Web-Based Intervention for Binge Eating Disorder

NCT06817863Phase 1Recruiting

A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity

NCT05560529Phase 4CompletedPrimary

Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder

NCT06752304Recruiting

A Longitudinal Study of Severe and Enduring Eating Disorders

NCT06703502CompletedPrimary

Evaluation of Pilot Online Binge Eating Disorder Group (BEG) in Under 18s.

NCT05035927Phase 2CompletedPrimary

Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder

Scroll to load more

Research Network

Activity Timeline